Patients with contraindications to daily oral HIV pre-exposure prophylaxis could soon access a PBS-subsidised long-acting injectable. Following its September meeting, the PBAC has recommended a…
Landmark study shows need for better access to PrEP in MSM living outside of 'urban gay areas', Professor Andrew Grulich says.
A student returns from a visit to family in Vietnam with a fever and widespread rash.
Efficacy rates for the therapy for women vary wildly from -49-75%.
The drug combination is now the most common strategy among Australian gay and bisexual men.
The 'very interesting' case was reported at the AIDS 2020 conference.
This benefit should be used to promote the drug among eligible men, researcher says.
Julian, 32, presents with a painful left knee that he can’t explain. When his partner leaves the exam room, he reveals something that might help …
The good news is that new diagnoses have hit an 18-year low: latest report.
Study on ART follows news of the seventh reported case of HIV transmission in a patient taking PrEP.